nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelaic Acid—AKR1D1—mammary gland—breast cancer	0.0612	0.414	CbGeAlD
Azelaic Acid—Vitiligo—Paclitaxel—breast cancer	0.0494	0.109	CcSEcCtD
Azelaic Acid—AKR1D1—female reproductive system—breast cancer	0.0253	0.171	CbGeAlD
Azelaic Acid—AKR1D1—endocrine gland—breast cancer	0.0214	0.145	CbGeAlD
Azelaic Acid—TYR—skin of body—breast cancer	0.0188	0.127	CbGeAlD
Azelaic Acid—Hypertrichosis—Exemestane—breast cancer	0.0178	0.0391	CcSEcCtD
Azelaic Acid—TYR—endocrine gland—breast cancer	0.0124	0.0841	CbGeAlD
Azelaic Acid—Vorinostat—NCOR1—breast cancer	0.00994	0.333	CrCbGaD
Azelaic Acid—Herpes labialis—Epirubicin—breast cancer	0.00931	0.0205	CcSEcCtD
Azelaic Acid—Herpes labialis—Doxorubicin—breast cancer	0.00861	0.019	CcSEcCtD
Azelaic Acid—TYR—lymph node—breast cancer	0.0086	0.0581	CbGeAlD
Azelaic Acid—Application site reaction—Goserelin—breast cancer	0.00836	0.0184	CcSEcCtD
Azelaic Acid—Oral herpes—Capecitabine—breast cancer	0.00823	0.0181	CcSEcCtD
Azelaic Acid—Leukoderma—Thiotepa—breast cancer	0.00789	0.0174	CcSEcCtD
Azelaic Acid—Alpha-Linolenic Acid—FABP7—breast cancer	0.00739	0.248	CrCbGaD
Azelaic Acid—Aminocaproic Acid—PLG—breast cancer	0.00731	0.245	CrCbGaD
Azelaic Acid—Localized exfoliation—Capecitabine—breast cancer	0.0072	0.0159	CcSEcCtD
Azelaic Acid—Skin exfoliation—Ixabepilone—breast cancer	0.00608	0.0134	CcSEcCtD
Azelaic Acid—Redness—Tamoxifen—breast cancer	0.00608	0.0134	CcSEcCtD
Azelaic Acid—Application site reaction—Fluorouracil—breast cancer	0.00592	0.013	CcSEcCtD
Azelaic Acid—Oral herpes—Epirubicin—breast cancer	0.00573	0.0126	CcSEcCtD
Azelaic Acid—Dry skin—Lapatinib—breast cancer	0.00563	0.0124	CcSEcCtD
Azelaic Acid—Oral herpes—Doxorubicin—breast cancer	0.0053	0.0117	CcSEcCtD
Azelaic Acid—Alprostadil—PTGER1—breast cancer	0.00517	0.173	CrCbGaD
Azelaic Acid—Tingling sensation—Melphalan—breast cancer	0.005	0.011	CcSEcCtD
Azelaic Acid—Acne—Goserelin—breast cancer	0.00466	0.0103	CcSEcCtD
Azelaic Acid—Dry skin—Letrozole—breast cancer	0.00399	0.0088	CcSEcCtD
Azelaic Acid—Skin exfoliation—Tamoxifen—breast cancer	0.00392	0.00864	CcSEcCtD
Azelaic Acid—Skin exfoliation—Melphalan—breast cancer	0.00384	0.00846	CcSEcCtD
Azelaic Acid—Paraesthesia—Fluoxymesterone—breast cancer	0.00382	0.00841	CcSEcCtD
Azelaic Acid—Redness—Paclitaxel—breast cancer	0.0035	0.00771	CcSEcCtD
Azelaic Acid—Tingling sensation—Fluorouracil—breast cancer	0.00345	0.00761	CcSEcCtD
Azelaic Acid—Stinging—Fluorouracil—breast cancer	0.00342	0.00755	CcSEcCtD
Azelaic Acid—Leukoderma—Methotrexate—breast cancer	0.0034	0.00748	CcSEcCtD
Azelaic Acid—Skin exfoliation—Vinorelbine—breast cancer	0.00335	0.00739	CcSEcCtD
Azelaic Acid—Dermatitis contact—Thiotepa—breast cancer	0.00332	0.00731	CcSEcCtD
Azelaic Acid—Skin exfoliation—Thiotepa—breast cancer	0.0032	0.00706	CcSEcCtD
Azelaic Acid—Leukoderma—Epirubicin—breast cancer	0.00318	0.007	CcSEcCtD
Azelaic Acid—Hypersensitivity—Fluoxymesterone—breast cancer	0.00313	0.0069	CcSEcCtD
Azelaic Acid—Redness—Docetaxel—breast cancer	0.00297	0.00654	CcSEcCtD
Azelaic Acid—Leukoderma—Doxorubicin—breast cancer	0.00294	0.00648	CcSEcCtD
Azelaic Acid—Tingling sensation—Paclitaxel—breast cancer	0.00294	0.00648	CcSEcCtD
Azelaic Acid—Dermatitis contact—Fluorouracil—breast cancer	0.00274	0.00604	CcSEcCtD
Azelaic Acid—Oedema—Toremifene—breast cancer	0.00274	0.00603	CcSEcCtD
Azelaic Acid—Pain—Carboplatin—breast cancer	0.00274	0.00603	CcSEcCtD
Azelaic Acid—Skin exfoliation—Gemcitabine—breast cancer	0.00269	0.00594	CcSEcCtD
Azelaic Acid—Erythema—Anastrozole—breast cancer	0.00262	0.00578	CcSEcCtD
Azelaic Acid—Dry skin—Goserelin—breast cancer	0.00261	0.00575	CcSEcCtD
Azelaic Acid—Paraesthesia—Fulvestrant—breast cancer	0.00249	0.00549	CcSEcCtD
Azelaic Acid—Tingling sensation—Capecitabine—breast cancer	0.00241	0.00532	CcSEcCtD
Azelaic Acid—Oedema—Exemestane—breast cancer	0.00241	0.00531	CcSEcCtD
Azelaic Acid—Pain—Fulvestrant—breast cancer	0.00237	0.00523	CcSEcCtD
Azelaic Acid—Pain—Toremifene—breast cancer	0.00234	0.00516	CcSEcCtD
Azelaic Acid—Oedema—Ixabepilone—breast cancer	0.00227	0.00501	CcSEcCtD
Azelaic Acid—Skin exfoliation—Paclitaxel—breast cancer	0.00226	0.00497	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Goserelin—breast cancer	0.00225	0.00495	CcSEcCtD
Azelaic Acid—Hypersensitivity—Lapatinib—breast cancer	0.00222	0.0049	CcSEcCtD
Azelaic Acid—Paraesthesia—Exemestane—breast cancer	0.00216	0.00477	CcSEcCtD
Azelaic Acid—Oedema—Letrozole—breast cancer	0.00214	0.00472	CcSEcCtD
Azelaic Acid—Oedema—Anastrozole—breast cancer	0.00214	0.00472	CcSEcCtD
Azelaic Acid—Pruritus—Lapatinib—breast cancer	0.00213	0.0047	CcSEcCtD
Azelaic Acid—Pain—Exemestane—breast cancer	0.00206	0.00454	CcSEcCtD
Azelaic Acid—Hypersensitivity—Fulvestrant—breast cancer	0.00204	0.0045	CcSEcCtD
Azelaic Acid—Paraesthesia—Ixabepilone—breast cancer	0.00204	0.0045	CcSEcCtD
Azelaic Acid—Redness—Epirubicin—breast cancer	0.002	0.00441	CcSEcCtD
Azelaic Acid—Pruritus—Fulvestrant—breast cancer	0.00196	0.00432	CcSEcCtD
Azelaic Acid—Pain—Ixabepilone—breast cancer	0.00194	0.00428	CcSEcCtD
Azelaic Acid—Pruritus—Toremifene—breast cancer	0.00194	0.00427	CcSEcCtD
Azelaic Acid—Paraesthesia—Letrozole—breast cancer	0.00192	0.00424	CcSEcCtD
Azelaic Acid—Paraesthesia—Anastrozole—breast cancer	0.00192	0.00424	CcSEcCtD
Azelaic Acid—Skin exfoliation—Docetaxel—breast cancer	0.00191	0.00421	CcSEcCtD
Azelaic Acid—Rash—Lapatinib—breast cancer	0.0019	0.00419	CcSEcCtD
Azelaic Acid—Dermatitis—Lapatinib—breast cancer	0.0019	0.00419	CcSEcCtD
Azelaic Acid—Redness—Doxorubicin—breast cancer	0.00185	0.00408	CcSEcCtD
Azelaic Acid—Skin exfoliation—Capecitabine—breast cancer	0.00185	0.00408	CcSEcCtD
Azelaic Acid—Dry skin—Fluorouracil—breast cancer	0.00185	0.00407	CcSEcCtD
Azelaic Acid—Pain—Letrozole—breast cancer	0.00183	0.00403	CcSEcCtD
Azelaic Acid—Pain—Anastrozole—breast cancer	0.00183	0.00403	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.0018	0.00489	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.0018	0.00489	CbGpPWpGaD
Azelaic Acid—Erythema—Tamoxifen—breast cancer	0.0018	0.00396	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—CYP3A4—breast cancer	0.00178	0.00483	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Exemestane—breast cancer	0.00178	0.00391	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.00177	0.0048	CbGpPWpGaD
Azelaic Acid—Rash—Fulvestrant—breast cancer	0.00175	0.00385	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—CYP1B1—breast cancer	0.00175	0.00474	CbGpPWpGaD
Azelaic Acid—Dermatitis—Fulvestrant—breast cancer	0.00175	0.00385	CcSEcCtD
Azelaic Acid—Pain—Raloxifene—breast cancer	0.00174	0.00383	CcSEcCtD
Azelaic Acid—Rash—Toremifene—breast cancer	0.00173	0.0038	CcSEcCtD
Azelaic Acid—Dermatitis—Toremifene—breast cancer	0.00172	0.0038	CcSEcCtD
Azelaic Acid—Erythema—Goserelin—breast cancer	0.00171	0.00378	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.00171	0.00464	CbGpPWpGaD
Azelaic Acid—Pruritus—Exemestane—breast cancer	0.0017	0.00376	CcSEcCtD
Azelaic Acid—Hypersensitivity—Ixabepilone—breast cancer	0.00168	0.00369	CcSEcCtD
Azelaic Acid—Stinging—Epirubicin—breast cancer	0.00167	0.00367	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—CYP19A1—breast cancer	0.00164	0.00446	CbGpPWpGaD
Azelaic Acid—Pruritus—Ixabepilone—breast cancer	0.00161	0.00354	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.00161	0.00436	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.00161	0.00436	CbGpPWpGaD
Azelaic Acid—Photosensitivity reaction—Fluorouracil—breast cancer	0.00159	0.0035	CcSEcCtD
Azelaic Acid—Hypersensitivity—Anastrozole—breast cancer	0.00158	0.00348	CcSEcCtD
Azelaic Acid—Dry skin—Paclitaxel—breast cancer	0.00157	0.00346	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.00156	0.00424	CbGpPWpGaD
Azelaic Acid—Stinging—Doxorubicin—breast cancer	0.00154	0.0034	CcSEcCtD
Azelaic Acid—Erythema—Vinorelbine—breast cancer	0.00154	0.00338	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—COMT—breast cancer	0.00153	0.00415	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.00152	0.00414	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metapathway biotransformation—GSTP1—breast cancer	0.00152	0.00413	CbGpPWpGaD
Azelaic Acid—Rash—Exemestane—breast cancer	0.00152	0.00335	CcSEcCtD
Azelaic Acid—Dermatitis—Exemestane—breast cancer	0.00152	0.00334	CcSEcCtD
Azelaic Acid—Pruritus—Letrozole—breast cancer	0.00151	0.00334	CcSEcCtD
Azelaic Acid—Pruritus—Anastrozole—breast cancer	0.00151	0.00334	CcSEcCtD
Azelaic Acid—Hypersensitivity—Idarubicin—breast cancer	0.0015	0.0033	CcSEcCtD
Azelaic Acid—Erythema—Thiotepa—breast cancer	0.00147	0.00323	CcSEcCtD
Azelaic Acid—Oedema—Tamoxifen—breast cancer	0.00147	0.00323	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.00145	0.00395	CbGpPWpGaD
Azelaic Acid—Oedema—Melphalan—breast cancer	0.00143	0.00316	CcSEcCtD
Azelaic Acid—Rash—Ixabepilone—breast cancer	0.00143	0.00316	CcSEcCtD
Azelaic Acid—Dermatitis—Ixabepilone—breast cancer	0.00143	0.00316	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.00141	0.00382	CbGpPWpGaD
Azelaic Acid—Pain—Chlorambucil—breast cancer	0.00141	0.0031	CcSEcCtD
Azelaic Acid—Oedema—Goserelin—breast cancer	0.0014	0.00308	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—GSTM1—breast cancer	0.0014	0.00379	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.00139	0.00378	CbGpPWpGaD
Azelaic Acid—Skin exfoliation—Methotrexate—breast cancer	0.00138	0.00304	CcSEcCtD
Azelaic Acid—Paraesthesia—Vinblastine—breast cancer	0.00135	0.00298	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Paclitaxel—breast cancer	0.00135	0.00298	CcSEcCtD
Azelaic Acid—Rash—Anastrozole—breast cancer	0.00135	0.00297	CcSEcCtD
Azelaic Acid—Rash—Letrozole—breast cancer	0.00135	0.00297	CcSEcCtD
Azelaic Acid—Dermatitis—Anastrozole—breast cancer	0.00135	0.00297	CcSEcCtD
Azelaic Acid—Dermatitis—Letrozole—breast cancer	0.00135	0.00297	CcSEcCtD
Azelaic Acid—Dermatitis contact—Epirubicin—breast cancer	0.00133	0.00294	CcSEcCtD
Azelaic Acid—Dry skin—Docetaxel—breast cancer	0.00133	0.00294	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—CYP1A1—breast cancer	0.00132	0.0036	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Tamoxifen—breast cancer	0.00132	0.0029	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.0013	0.00352	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.0013	0.00352	CbGpPWpGaD
Azelaic Acid—Dry skin—Capecitabine—breast cancer	0.00129	0.00284	CcSEcCtD
Azelaic Acid—Pain—Vinblastine—breast cancer	0.00129	0.00284	CcSEcCtD
Azelaic Acid—Skin exfoliation—Epirubicin—breast cancer	0.00129	0.00284	CcSEcCtD
Azelaic Acid—Paraesthesia—Melphalan—breast cancer	0.00129	0.00284	CcSEcCtD
Azelaic Acid—Rash—Raloxifene—breast cancer	0.00128	0.00282	CcSEcCtD
Azelaic Acid—Rash—Idarubicin—breast cancer	0.00128	0.00282	CcSEcCtD
Azelaic Acid—Dermatitis—Idarubicin—breast cancer	0.00128	0.00282	CcSEcCtD
Azelaic Acid—Dermatitis—Raloxifene—breast cancer	0.00128	0.00282	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.00128	0.00347	CbGpPWpGaD
Azelaic Acid—Erythema—Mitoxantrone—breast cancer	0.00127	0.00279	CcSEcCtD
Azelaic Acid—Paraesthesia—Goserelin—breast cancer	0.00126	0.00277	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.00125	0.00341	CbGpPWpGaD
Azelaic Acid—Pain—Tamoxifen—breast cancer	0.00125	0.00276	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.00125	0.00339	CbGpPWpGaD
Azelaic Acid—Dermatitis contact—Doxorubicin—breast cancer	0.00124	0.00272	CcSEcCtD
Azelaic Acid—Erythema—Gemcitabine—breast cancer	0.00123	0.00272	CcSEcCtD
Azelaic Acid—Pain—Melphalan—breast cancer	0.00123	0.0027	CcSEcCtD
Azelaic Acid—Asthma—Capecitabine—breast cancer	0.00122	0.00268	CcSEcCtD
Azelaic Acid—Erythema—Fluorouracil—breast cancer	0.00121	0.00267	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—SYNJ2—breast cancer	0.00121	0.00329	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Chlorambucil—breast cancer	0.00121	0.00267	CcSEcCtD
Azelaic Acid—Pain—Goserelin—breast cancer	0.0012	0.00264	CcSEcCtD
Azelaic Acid—Skin exfoliation—Doxorubicin—breast cancer	0.00119	0.00263	CcSEcCtD
Azelaic Acid—Pruritus—Chlorambucil—breast cancer	0.00116	0.00257	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.00115	0.00313	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.00114	0.0031	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NDUFS3—breast cancer	0.00113	0.00306	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Vinorelbine—breast cancer	0.00113	0.00248	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.00111	0.00302	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Vinblastine—breast cancer	0.00111	0.00245	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Capecitabine—breast cancer	0.00111	0.00245	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.00108	0.00294	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—SYNJ2—breast cancer	0.00108	0.00293	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Tamoxifen—breast cancer	0.00108	0.00238	CcSEcCtD
Azelaic Acid—Paraesthesia—Thiotepa—breast cancer	0.00107	0.00237	CcSEcCtD
Azelaic Acid—Pain—Vinorelbine—breast cancer	0.00107	0.00236	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CHST9—breast cancer	0.00106	0.00288	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Melphalan—breast cancer	0.00106	0.00233	CcSEcCtD
Azelaic Acid—Pruritus—Tamoxifen—breast cancer	0.00104	0.00228	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.00104	0.00281	CbGpPWpGaD
Azelaic Acid—Oedema—Irinotecan—breast cancer	0.00103	0.00228	CcSEcCtD
Azelaic Acid—Oedema—Mitoxantrone—breast cancer	0.00103	0.00228	CcSEcCtD
Azelaic Acid—Erythema—Paclitaxel—breast cancer	0.00103	0.00228	CcSEcCtD
Azelaic Acid—Hypersensitivity—Goserelin—breast cancer	0.00103	0.00227	CcSEcCtD
Azelaic Acid—Pain—Thiotepa—breast cancer	0.00102	0.00226	CcSEcCtD
Azelaic Acid—Pruritus—Melphalan—breast cancer	0.00101	0.00224	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.00101	0.00273	CbGpPWpGaD
Azelaic Acid—Oedema—Gemcitabine—breast cancer	0.00101	0.00222	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—NDUFS3—breast cancer	0.001	0.00273	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—COX11—breast cancer	0.001	0.00273	CbGpPWpGaD
Azelaic Acid—Pruritus—Goserelin—breast cancer	0.00099	0.00218	CcSEcCtD
Azelaic Acid—Oedema—Fluorouracil—breast cancer	0.00099	0.00218	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.000988	0.00268	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.000966	0.00262	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.000958	0.0026	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CHST9—breast cancer	0.000945	0.00256	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Irinotecan—breast cancer	0.000928	0.00205	CcSEcCtD
Azelaic Acid—Paraesthesia—Mitoxantrone—breast cancer	0.000928	0.00205	CcSEcCtD
Azelaic Acid—Rash—Tamoxifen—breast cancer	0.000924	0.00204	CcSEcCtD
Azelaic Acid—Hypersensitivity—Vinorelbine—breast cancer	0.000923	0.00203	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.000923	0.00251	CbGpPWpGaD
Azelaic Acid—Dermatitis—Tamoxifen—breast cancer	0.000923	0.00203	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CDA—breast cancer	0.000919	0.00249	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SHMT1—breast cancer	0.000919	0.00249	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000907	0.00246	CbGpPWpGaD
Azelaic Acid—Asthma—Methotrexate—breast cancer	0.000906	0.002	CcSEcCtD
Azelaic Acid—Rash—Melphalan—breast cancer	0.000905	0.00199	CcSEcCtD
Azelaic Acid—Paraesthesia—Gemcitabine—breast cancer	0.000904	0.00199	CcSEcCtD
Azelaic Acid—Dermatitis—Melphalan—breast cancer	0.000904	0.00199	CcSEcCtD
Azelaic Acid—Dry skin—Epirubicin—breast cancer	0.000899	0.00198	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.000898	0.00244	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.000898	0.00244	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—COX11—breast cancer	0.000895	0.00243	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Fluorouracil—breast cancer	0.000889	0.00196	CcSEcCtD
Azelaic Acid—Pruritus—Vinorelbine—breast cancer	0.000887	0.00195	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—SLC2A5—breast cancer	0.000885	0.0024	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SLCO1B1—breast cancer	0.000885	0.0024	CbGpPWpGaD
Azelaic Acid—Pain—Irinotecan—breast cancer	0.000884	0.00195	CcSEcCtD
Azelaic Acid—Pain—Mitoxantrone—breast cancer	0.000884	0.00195	CcSEcCtD
Azelaic Acid—Rash—Goserelin—breast cancer	0.000882	0.00194	CcSEcCtD
Azelaic Acid—Hypersensitivity—Thiotepa—breast cancer	0.000882	0.00194	CcSEcCtD
Azelaic Acid—Dermatitis—Goserelin—breast cancer	0.000881	0.00194	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.000881	0.00239	CbGpPWpGaD
Azelaic Acid—Erythema—Docetaxel—breast cancer	0.000875	0.00193	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.000865	0.00235	CbGpPWpGaD
Azelaic Acid—Pain—Gemcitabine—breast cancer	0.000861	0.0019	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—APRT—breast cancer	0.000854	0.00232	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.000854	0.00232	CbGpPWpGaD
Azelaic Acid—Erythema—Capecitabine—breast cancer	0.000848	0.00187	CcSEcCtD
Azelaic Acid—Asthma—Epirubicin—breast cancer	0.000847	0.00187	CcSEcCtD
Azelaic Acid—Pruritus—Thiotepa—breast cancer	0.000847	0.00187	CcSEcCtD
Azelaic Acid—Pain—Fluorouracil—breast cancer	0.000847	0.00187	CcSEcCtD
Azelaic Acid—Oedema—Paclitaxel—breast cancer	0.000843	0.00186	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.000838	0.00228	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000835	0.00227	CbGpPWpGaD
Azelaic Acid—Dry skin—Doxorubicin—breast cancer	0.000832	0.00183	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Methotrexate—breast cancer	0.000827	0.00182	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—CDA—breast cancer	0.000819	0.00222	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—SHMT1—breast cancer	0.000819	0.00222	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000809	0.00219	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ESRRA—breast cancer	0.000803	0.00218	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ANGPTL4—breast cancer	0.000803	0.00218	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.0008	0.00217	CbGpPWpGaD
Azelaic Acid—Rash—Vinorelbine—breast cancer	0.00079	0.00174	CcSEcCtD
Azelaic Acid—Dermatitis—Vinorelbine—breast cancer	0.000789	0.00174	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SLCO1B1—breast cancer	0.000788	0.00214	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—SLC2A5—breast cancer	0.000788	0.00214	CbGpPWpGaD
Azelaic Acid—Asthma—Doxorubicin—breast cancer	0.000784	0.00173	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Epirubicin—breast cancer	0.000774	0.0017	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.000771	0.00209	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.000764	0.00207	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Mitoxantrone—breast cancer	0.000762	0.00168	CcSEcCtD
Azelaic Acid—Hypersensitivity—Irinotecan—breast cancer	0.000762	0.00168	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—HADHB—breast cancer	0.000761	0.00207	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GPI—breast cancer	0.000761	0.00207	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—APRT—breast cancer	0.000761	0.00207	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Paclitaxel—breast cancer	0.000757	0.00167	CcSEcCtD
Azelaic Acid—Rash—Thiotepa—breast cancer	0.000755	0.00166	CcSEcCtD
Azelaic Acid—Dermatitis—Thiotepa—breast cancer	0.000754	0.00166	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.000747	0.00203	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000744	0.00202	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Fluorouracil—breast cancer	0.000729	0.00161	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000729	0.00198	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ALDH7A1—breast cancer	0.000726	0.00197	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ALDH1A1—breast cancer	0.000726	0.00197	CbGpPWpGaD
Azelaic Acid—Pain—Paclitaxel—breast cancer	0.000721	0.00159	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.000718	0.00195	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ESRRA—breast cancer	0.000716	0.00194	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ANGPTL4—breast cancer	0.000716	0.00194	CbGpPWpGaD
Azelaic Acid—Photosensitivity reaction—Doxorubicin—breast cancer	0.000716	0.00158	CcSEcCtD
Azelaic Acid—Oedema—Docetaxel—breast cancer	0.000715	0.00157	CcSEcCtD
Azelaic Acid—Pruritus—Gemcitabine—breast cancer	0.000712	0.00157	CcSEcCtD
Azelaic Acid—Pruritus—Fluorouracil—breast cancer	0.0007	0.00154	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—ADSL—breast cancer	0.000696	0.00189	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—FHL2—breast cancer	0.000696	0.00189	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PHGDH—breast cancer	0.000696	0.00189	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NME1—breast cancer	0.000696	0.00189	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—UMPS—breast cancer	0.000696	0.00189	CbGpPWpGaD
Azelaic Acid—Oedema—Capecitabine—breast cancer	0.000692	0.00152	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—BRIP1—breast cancer	0.000683	0.00185	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—LDHB—breast cancer	0.000683	0.00185	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HPSE—breast cancer	0.000683	0.00185	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.000681	0.00185	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GPI—breast cancer	0.000679	0.00184	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HADHB—breast cancer	0.000679	0.00184	CbGpPWpGaD
Azelaic Acid—Rash—Irinotecan—breast cancer	0.000652	0.00144	CcSEcCtD
Azelaic Acid—Rash—Mitoxantrone—breast cancer	0.000652	0.00144	CcSEcCtD
Azelaic Acid—Dermatitis—Mitoxantrone—breast cancer	0.000651	0.00143	CcSEcCtD
Azelaic Acid—Dermatitis—Irinotecan—breast cancer	0.000651	0.00143	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000649	0.00176	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ALDH1A1—breast cancer	0.000647	0.00176	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ABCC1—breast cancer	0.000647	0.00176	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTA3—breast cancer	0.000647	0.00176	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ALDH7A1—breast cancer	0.000647	0.00176	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HMMR—breast cancer	0.000647	0.00176	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Docetaxel—breast cancer	0.000642	0.00141	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.00064	0.00174	CbGpPWpGaD
Azelaic Acid—Rash—Gemcitabine—breast cancer	0.000635	0.0014	CcSEcCtD
Azelaic Acid—Dermatitis—Gemcitabine—breast cancer	0.000634	0.0014	CcSEcCtD
Azelaic Acid—Erythema—Methotrexate—breast cancer	0.000631	0.00139	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—PPARGC1B—breast cancer	0.000627	0.0017	CbGpPWpGaD
Azelaic Acid—Rash—Fluorouracil—breast cancer	0.000624	0.00138	CcSEcCtD
Azelaic Acid—Dermatitis—Fluorouracil—breast cancer	0.000624	0.00137	CcSEcCtD
Azelaic Acid—Paraesthesia—Capecitabine—breast cancer	0.000621	0.00137	CcSEcCtD
Azelaic Acid—Hypersensitivity—Paclitaxel—breast cancer	0.000621	0.00137	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—PHGDH—breast cancer	0.000621	0.00168	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—UMPS—breast cancer	0.000621	0.00168	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ADSL—breast cancer	0.000621	0.00168	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—FHL2—breast cancer	0.000621	0.00168	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NME1—breast cancer	0.000621	0.00168	CbGpPWpGaD
Azelaic Acid—Pain—Docetaxel—breast cancer	0.000611	0.00135	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.00061	0.00166	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.00061	0.00166	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—BRIP1—breast cancer	0.000609	0.00165	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HPSE—breast cancer	0.000609	0.00165	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—LDHB—breast cancer	0.000609	0.00165	CbGpPWpGaD
Azelaic Acid—Pruritus—Paclitaxel—breast cancer	0.000596	0.00131	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CA9—breast cancer	0.000592	0.00161	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTA4—breast cancer	0.000592	0.00161	CbGpPWpGaD
Azelaic Acid—Pain—Capecitabine—breast cancer	0.000592	0.0013	CcSEcCtD
Azelaic Acid—Erythema—Epirubicin—breast cancer	0.000591	0.0013	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000585	0.00159	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000579	0.00157	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GPX2—breast cancer	0.000577	0.00157	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTA2—breast cancer	0.000577	0.00157	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTA3—breast cancer	0.000577	0.00157	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ABCC1—breast cancer	0.000577	0.00157	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HMMR—breast cancer	0.000577	0.00157	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SULT1A1—breast cancer	0.00057	0.00155	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GPX4—breast cancer	0.00057	0.00155	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PPARGC1B—breast cancer	0.000559	0.00152	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTA1—breast cancer	0.000557	0.00151	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—IDH1—breast cancer	0.000557	0.00151	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NAT2—breast cancer	0.00055	0.00149	CbGpPWpGaD
Azelaic Acid—Erythema—Doxorubicin—breast cancer	0.000546	0.0012	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.000544	0.00148	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.000544	0.00148	CbGpPWpGaD
Azelaic Acid—Rash—Paclitaxel—breast cancer	0.000532	0.00117	CcSEcCtD
Azelaic Acid—Dermatitis—Paclitaxel—breast cancer	0.000531	0.00117	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—GSTA4—breast cancer	0.000528	0.00143	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CA9—breast cancer	0.000528	0.00143	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Docetaxel—breast cancer	0.000526	0.00116	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000521	0.00141	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000516	0.0014	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GPX2—breast cancer	0.000514	0.0014	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTA2—breast cancer	0.000514	0.0014	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Capecitabine—breast cancer	0.00051	0.00112	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SULT1A1—breast cancer	0.000508	0.00138	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GPX4—breast cancer	0.000508	0.00138	CbGpPWpGaD
Azelaic Acid—Pruritus—Docetaxel—breast cancer	0.000506	0.00111	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000498	0.00135	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—IDH1—breast cancer	0.000496	0.00135	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTA1—breast cancer	0.000496	0.00135	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NAT2—breast cancer	0.000491	0.00133	CbGpPWpGaD
Azelaic Acid—Pruritus—Capecitabine—breast cancer	0.000489	0.00108	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—MED12—breast cancer	0.000483	0.00131	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—DPYD—breast cancer	0.000483	0.00131	CbGpPWpGaD
Azelaic Acid—Oedema—Epirubicin—breast cancer	0.000482	0.00106	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—ALDOA—breast cancer	0.000475	0.00129	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Methotrexate—breast cancer	0.000462	0.00102	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—NCOA3—breast cancer	0.000461	0.00125	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SLC2A2—breast cancer	0.000458	0.00124	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000453	0.00123	CbGpPWpGaD
Azelaic Acid—Rash—Docetaxel—breast cancer	0.000451	0.000993	CcSEcCtD
Azelaic Acid—Dermatitis—Docetaxel—breast cancer	0.00045	0.000992	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CPT1A—breast cancer	0.000449	0.00122	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—MTR—breast cancer	0.000449	0.00122	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ABCG2—breast cancer	0.000449	0.00122	CbGpPWpGaD
Azelaic Acid—Oedema—Doxorubicin—breast cancer	0.000446	0.000983	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000444	0.0012	CbGpPWpGaD
Azelaic Acid—Pain—Methotrexate—breast cancer	0.00044	0.00097	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—HPGDS—breast cancer	0.00044	0.00119	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HBA1—breast cancer	0.000437	0.00119	CbGpPWpGaD
Azelaic Acid—Rash—Capecitabine—breast cancer	0.000436	0.000961	CcSEcCtD
Azelaic Acid—Dermatitis—Capecitabine—breast cancer	0.000436	0.00096	CcSEcCtD
Azelaic Acid—Paraesthesia—Epirubicin—breast cancer	0.000433	0.000954	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—MED12—breast cancer	0.00043	0.00117	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—DPYD—breast cancer	0.00043	0.00117	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ACHE—breast cancer	0.000427	0.00116	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTT1—breast cancer	0.000427	0.00116	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ALDOA—breast cancer	0.000424	0.00115	CbGpPWpGaD
Azelaic Acid—Pain—Epirubicin—breast cancer	0.000412	0.000908	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—NCOA3—breast cancer	0.000411	0.00112	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—SLC2A2—breast cancer	0.000408	0.00111	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CYP17A1—breast cancer	0.000404	0.0011	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000404	0.0011	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Doxorubicin—breast cancer	0.0004	0.000882	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—PTGS1—breast cancer	0.0004	0.00109	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ENO1—breast cancer	0.0004	0.00109	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—MTR—breast cancer	0.0004	0.00109	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CPT1A—breast cancer	0.0004	0.00109	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ABCG2—breast cancer	0.0004	0.00109	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000399	0.00108	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000393	0.00107	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HPGDS—breast cancer	0.000392	0.00106	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CYP2D6—breast cancer	0.000392	0.00106	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HBA1—breast cancer	0.00039	0.00106	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NCOA2—breast cancer	0.000385	0.00104	CbGpPWpGaD
Azelaic Acid—Pain—Doxorubicin—breast cancer	0.000381	0.00084	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—ACHE—breast cancer	0.00038	0.00103	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTT1—breast cancer	0.00038	0.00103	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Methotrexate—breast cancer	0.000379	0.000836	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—FASN—breast cancer	0.000373	0.00101	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—BCHE—breast cancer	0.000372	0.00101	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SLC5A5—breast cancer	0.000367	0.000997	CbGpPWpGaD
Azelaic Acid—Pruritus—Methotrexate—breast cancer	0.000364	0.000803	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—CYP17A1—breast cancer	0.00036	0.000977	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PTGS1—breast cancer	0.000357	0.000967	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ENO1—breast cancer	0.000357	0.000967	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000355	0.000964	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Epirubicin—breast cancer	0.000355	0.000782	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—NQO1—breast cancer	0.000355	0.000963	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SLC2A1—breast cancer	0.000355	0.000963	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000351	0.000952	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CYP2D6—breast cancer	0.00035	0.000949	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000347	0.000943	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CYP3A4—breast cancer	0.000346	0.000939	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000344	0.000934	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NCOA2—breast cancer	0.000343	0.000931	CbGpPWpGaD
Azelaic Acid—Pruritus—Epirubicin—breast cancer	0.000341	0.000751	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CYP1B1—breast cancer	0.00034	0.000923	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HSP90AA1—breast cancer	0.000334	0.000905	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—FASN—breast cancer	0.000333	0.000903	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—BCHE—breast cancer	0.000331	0.000899	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Doxorubicin—breast cancer	0.000329	0.000724	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SLC5A5—breast cancer	0.000327	0.000888	CbGpPWpGaD
Azelaic Acid—Rash—Methotrexate—breast cancer	0.000325	0.000716	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—NCOA1—breast cancer	0.000324	0.00088	CbGpPWpGaD
Azelaic Acid—Dermatitis—Methotrexate—breast cancer	0.000324	0.000715	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—STK11—breast cancer	0.00032	0.000868	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CYP19A1—breast cancer	0.00032	0.000868	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NQO1—breast cancer	0.000316	0.000858	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—SLC2A1—breast cancer	0.000316	0.000858	CbGpPWpGaD
Azelaic Acid—Pruritus—Doxorubicin—breast cancer	0.000315	0.000695	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.00031	0.00084	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CYP3A4—breast cancer	0.000308	0.000837	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000307	0.000833	CbGpPWpGaD
Azelaic Acid—Rash—Epirubicin—breast cancer	0.000304	0.00067	CcSEcCtD
Azelaic Acid—Dermatitis—Epirubicin—breast cancer	0.000304	0.000669	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—CYP1B1—breast cancer	0.000303	0.000823	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.0003	0.000815	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HSP90AA1—breast cancer	0.000297	0.000807	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—COMT—breast cancer	0.000297	0.000807	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTP1—breast cancer	0.000296	0.000803	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HMOX1—breast cancer	0.000292	0.000792	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ITPR1—breast cancer	0.000291	0.00079	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NCOA1—breast cancer	0.000289	0.000785	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CYP19A1—breast cancer	0.000285	0.000773	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—STK11—breast cancer	0.000285	0.000773	CbGpPWpGaD
Azelaic Acid—Rash—Doxorubicin—breast cancer	0.000281	0.00062	CcSEcCtD
Azelaic Acid—Dermatitis—Doxorubicin—breast cancer	0.000281	0.000619	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—ABCB1—breast cancer	0.00028	0.00076	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—TYMS—breast cancer	0.000275	0.000746	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PLA2G4A—breast cancer	0.000272	0.000738	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTM1—breast cancer	0.000272	0.000738	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NCOR1—breast cancer	0.000272	0.000738	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000268	0.000726	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—COMT—breast cancer	0.000265	0.000719	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTP1—breast cancer	0.000264	0.000716	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GPX1—breast cancer	0.00026	0.000707	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HMOX1—breast cancer	0.00026	0.000706	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ITPR1—breast cancer	0.000259	0.000704	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CYP1A1—breast cancer	0.000258	0.000699	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ERCC2—breast cancer	0.000256	0.000694	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ABCB1—breast cancer	0.00025	0.000677	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—TYMS—breast cancer	0.000245	0.000665	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTM1—breast cancer	0.000242	0.000658	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NCOR1—breast cancer	0.000242	0.000658	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PLA2G4A—breast cancer	0.000242	0.000658	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—MTHFR—breast cancer	0.00024	0.000652	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GPX1—breast cancer	0.000232	0.00063	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CYP1A1—breast cancer	0.00023	0.000623	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ERCC2—breast cancer	0.000228	0.000618	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CAV1—breast cancer	0.000222	0.000601	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—MTHFR—breast cancer	0.000214	0.000581	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000212	0.000575	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CG—breast cancer	0.000202	0.000548	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CAV1—breast cancer	0.000198	0.000536	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000189	0.000512	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CG—breast cancer	0.00018	0.000488	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CD—breast cancer	0.000177	0.000482	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ALB—breast cancer	0.000175	0.000475	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NOS3—breast cancer	0.000168	0.000455	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CD—breast cancer	0.000158	0.000429	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ALB—breast cancer	0.000156	0.000424	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CB—breast cancer	0.000155	0.00042	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PTGS2—breast cancer	0.000153	0.000416	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NOS3—breast cancer	0.000149	0.000405	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CB—breast cancer	0.000138	0.000374	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PTGS2—breast cancer	0.000137	0.000371	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PTEN—breast cancer	0.000134	0.000363	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PTEN—breast cancer	0.000119	0.000323	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CA—breast cancer	9.43e-05	0.000256	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CA—breast cancer	8.41e-05	0.000228	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—AKT1—breast cancer	7.7e-05	0.000209	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—AKT1—breast cancer	6.87e-05	0.000186	CbGpPWpGaD
